Search | IOVS | ARVO Journals

Showing 1 – 20 of 30

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2022

Characterization of unequivocal haplotypes that encode the 20q13 modifier for variable ages-at-onset of primary open-angle glaucoma

Vincent Raymond; Pascal Belleau; Stéphane Dubois; Sylvie Desjardins; Rose Arseneault; Patrick Laplante; Eric Shink; Jean-Louis Anctil; Gilles Côté; Marcel Amyot; Michael A. Walter

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1128. doi:

ARVO Annual Meeting Abstract July 2018

Pigment Dispersion Syndrome and Pigmentary Glaucoma Associated Variants in Premelanosome Protein ( PMEL ) Cause Protein Processing and Fibrillogenesis Defects

Adrian Lahola-Chomiak; Baojian Fan; Tim Footz; David S Greenfield; Robert Ritch; Jamie E. Craig; Janey L Wiggs; Ordan J Lehmann; Michael A Walter

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3020. doi:

ARVO Annual Meeting Abstract July 2018

Targeted next generation amplicon sequencing for candidate genes of Pigment Dispersion Syndrome and Pigmentary Glaucoma

Tim Footz; Adrian Lahola-Chomiak; Ordan J Lehmann; Janey L Wiggs; Michael A Walter

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5140. doi:

ARVO Annual Meeting Abstract July 2018

Dissecting the Role of the Premelanosome Protein Gene ( PMEL ) in the Development of Pigmentary Glaucoma Using the Zebrafish Animal Model

Kim Nguyen-Phuoc; Gavin Neil; Tim Footz; Adrian Lahola-Chomiak; Ordan J Lehmann; Michael A Walter; W. Ted Allison

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5156. doi:

Glaucoma May 2018

FOXC1 Regulates Expression of Prostaglandin Receptors Leading to an Attenuated Response to Latanoprost

PDF

Lance P. Doucette; Tim Footz; Michael A. Walter
TAGS: glaucoma, latanoprost, phenotype, prostaglandin receptor, prostaglandins, attenuation, proteins, rna, rna, small interfering
Invest. Ophthalmol. Vis. Sci.. 2018; 59(6):2548-2554. doi: https://doi.org/10.1167/iovs.17-23223

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2017

Genetic Etiology of Pigmentary Dispersion Syndrome/Pigmentary Glaucoma

Adrian Alexander Lahola-Chomiak; Tim Footz; Thien-Kim Nguyen-Phuoc; Ordan J Lehmann; Michael A Walter

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2131. doi:

ARVO Annual Meeting Abstract June 2017

Nature of the endophenotypes associated with the modifier for age-at-onset of glaucoma mapping at 20q13

Vincent Raymond; Pascal Belleau; Rose Arseneault; Stéphane Dubois; Jean-Louis Anctil; Gilles Côté; Marcel Amyot; Fahed Elian; Michael A Walter

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3425. doi:

ARVO Annual Meeting Abstract September 2016

Whole exome sequencing identifies new candidate genes for Pigment Dispersion Syndrome

Tim Footz; Ordan J Lehmann; Michael A Walter

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):795. doi:

ARVO Annual Meeting Abstract September 2016

Characterization of FOXC1 mutations in patients with Axenfeld-Rieger syndrome

Morteza Seifi; Tim Footz; Michael A Walter

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):798. doi:

ARVO Annual Meeting Abstract September 2016

A Method to Evaluate the Roles of FOXC1 and PITX2 in the Regulation of Micro RNAs

Lance Patrick Doucette; Tim Footz; Michael A Walter

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):796. doi:

ARVO Annual Meeting Abstract June 2015

FOXC1 directly regulates prostaglandin receptors EP2, EP3, and EP4: A potential molecular explanation for prostaglandin resistant glaucoma in Axenfeld-Rieger Syndrome.

Lance Patrick Doucette; Timothy Footz; Michael A Walter

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5807. doi:

ARVO Annual Meeting Abstract April 2014

Molecular Analysis of Glaucoma in Axenfeld-Rieger Syndrome Patients Resistant to Prostaglandin Based Therapies

Lance Patrick Doucette; Tim Footz; Alexandra Rasnitsyn; Michael A Walter

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1280. doi:

ARVO Annual Meeting Abstract April 2014

Analysis of Exocytosis Regulation by Transcription Factor FOXC1 and its Role in Axenfeld-Rieger Syndrome Pathogenesis

Alexandra Rasnitsyn; Tim Footz; Lance Patrick Doucette; May Yu; Michael A Walter

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3802. doi:

ARVO Annual Meeting Abstract April 2014

Discovery of a novel deletion in PITX2 by dye-based quantitative PCR confirms that haploinsufficiency is a disease-causing mechanism for Axenfeld-Rieger Syndrome

Morteza Seifi; Tim Footz; Ebtesam M Abdalla; Karim M Nabil; Ghada M Elhady; Robert Ritch; Michael A Walter

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):6416. doi:

ARVO Annual Meeting Abstract March 2012

Genetic Architecture Of Open-angle Glaucoma: Modifiers Act Primarly By Causing Premature Elevation Of Intra-ocular Pressures

Vincent Raymond; Pascal Belleau; Stephane Dubois; Karine Lebel; Rose Arseneault; Eric Shink; Jean-Louis Anctil; Gilles Côté; Michael A. Walter; Marcel Amyot

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):5294. doi:

Biochemistry and Molecular Biology September 2011

PITX2 Is Involved in Stress Response in Cultured Human Trabecular Meshwork Cells through Regulation of SLC13A3

PDF

M. Hermina Strungaru; Tim Footz; Yi Liu; Fred B. Berry; Pascal Belleau; Elena V. Semina; Vincent Raymond; Michael A. Walter
TAGS: candidate disease gene, hormones, regulation, stress response, trabecular meshwork, zebrafish, glaucoma, dna, genes, chromatin
Invest. Ophthalmol. Vis. Sci.. 2011; 52(10):7625-7633. doi: https://doi.org/10.1167/iovs.10-6967

Includes: Supplemental Content

ARVO Annual Meeting Abstract April 2011

Involvement Of Pitx2 In Ocular Cellular Stress Response Through Regulation Of SLC13A3

Michael A. Walter; Tim Footz; Vincent Raymond; Fred Berry; Pascal Belleau; Marcela H. Strungaru

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):76. doi:

ARVO Annual Meeting Abstract April 2011

Dissection Of Quantitative Endophenotypes For Glaucoma In MYOC Mutant Carriers

Vincent Raymond; Pascal Belleau; Rose Arseneault; Stéphane Dubois; Jean-Louis Anctil; Gilles Côté; Marcel Amyot; Eric Shink; Michael A. Walter; Québec Glaucoma Network

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):2416. doi:

Biochemistry and Molecular Biology August 2009

Severe Molecular Defects of a Novel FOXC1 W152G Mutation Result in Aniridia

PDF

Yoko A. Ito; Tim K. Footz; Fred B. Berry; Farideh Mirzayans; May Yu; Arif O. Khan; Michael A. Walter
TAGS: aniridia, mutation, proteins, mutant proteins
Invest. Ophthalmol. Vis. Sci.. 2009; 50(8):3573-3579. doi: https://doi.org/10.1167/iovs.08-3032

Biochemistry and Molecular Biology June 2009

Analysis of Mutations of the PITX2 Transcription Factor Found in Patients with Axenfeld-Rieger Syndrome

PDF

Tim Footz; Faisal Idrees; Moulinath Acharya; Kathy Kozlowski; Michael A. Walter
TAGS: mutation, proteins, syndrome, transcription factor, dna, trans-activation (genetics), electrophoretic mobility shift assay
Invest. Ophthalmol. Vis. Sci.. 2009; 50(6):2599-2606. doi: https://doi.org/10.1167/iovs.08-3251

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Characterization of unequivocal haplotypes that encode the 20q13 modifier for variable ages-at-onset of primary open-angle glaucoma

Pigment Dispersion Syndrome and Pigmentary Glaucoma Associated Variants in Premelanosome Protein ( PMEL ) Cause Protein Processing and Fibrillogenesis Defects

Targeted next generation amplicon sequencing for candidate genes of Pigment Dispersion Syndrome and Pigmentary Glaucoma

Dissecting the Role of the Premelanosome Protein Gene ( PMEL ) in the Development of Pigmentary Glaucoma Using the Zebrafish Animal Model

FOXC1 Regulates Expression of Prostaglandin Receptors Leading to an Attenuated Response to Latanoprost

Genetic Etiology of Pigmentary Dispersion Syndrome/Pigmentary Glaucoma

Nature of the endophenotypes associated with the modifier for age-at-onset of glaucoma mapping at 20q13

Whole exome sequencing identifies new candidate genes for Pigment Dispersion Syndrome

Characterization of FOXC1 mutations in patients with Axenfeld-Rieger syndrome

A Method to Evaluate the Roles of FOXC1 and PITX2 in the Regulation of Micro RNAs

FOXC1 directly regulates prostaglandin receptors EP2, EP3, and EP4: A potential molecular explanation for prostaglandin resistant glaucoma in Axenfeld-Rieger Syndrome.

Molecular Analysis of Glaucoma in Axenfeld-Rieger Syndrome Patients Resistant to Prostaglandin Based Therapies

Analysis of Exocytosis Regulation by Transcription Factor FOXC1 and its Role in Axenfeld-Rieger Syndrome Pathogenesis

Discovery of a novel deletion in PITX2 by dye-based quantitative PCR confirms that haploinsufficiency is a disease-causing mechanism for Axenfeld-Rieger Syndrome

Genetic Architecture Of Open-angle Glaucoma: Modifiers Act Primarly By Causing Premature Elevation Of Intra-ocular Pressures

PITX2 Is Involved in Stress Response in Cultured Human Trabecular Meshwork Cells through Regulation of SLC13A3

Involvement Of Pitx2 In Ocular Cellular Stress Response Through Regulation Of SLC13A3

Dissection Of Quantitative Endophenotypes For Glaucoma In MYOC Mutant Carriers

Severe Molecular Defects of a Novel FOXC1 W152G Mutation Result in Aniridia

Analysis of Mutations of the PITX2 Transcription Factor Found in Patients with Axenfeld-Rieger Syndrome

To View More...

You must be signed into an individual account to use this feature.